Napp | PCDS National | Diabetes on the Net

Diabetes on the Net is intended for healthcare professionals

Company Profile

Napp Pharmaceuticals Limited is a UK healthcare company with a strong track record in bringing high-quality, innovative medicines to UK health professionals and their patients. We strive to offer new medicines and initiatives that support the NHS in delivering effective, high-quality, sustainable healthcare for the benefit of patients

This promotional resource page and the promotional materials included have been organised and funded by Napp Pharmaceuticals Limited. Napp products will be discussed. 

CREDENCE: A paradigm shift in the management of Diabetic Kidney Disease (DKD)

This promotional video presentation was originally broadcast on 5 November 2020. Please note that the speakers are not able to answer questions from attendees watching the video on-demand.

Resources

PDF Download

Canagliflozin and renal outcomes in type 2 diabetes and nephropathy

PDF Download

How to initiate and maintain patients on Invokana

Job code: UK/INV-20154s

Date of prep: October 2020

Practical experiences from running an adeno-associated virus gene therapy trials: The Principal Investigator’s perspective

XX September 2020

Complete the registration form

XX Month 2020

Complete the registration form

We use cookies to ensure that we give you the best experience on our website. Some may have been set already. If you continue without changing your settings, we’ll assume that you are happy to receive all cookies on this website. Read about how we use cookies. If you have any concerns about this, please click here to find out more.

* Mandatory Field
Your data is being collected by OmniaMed Communications on behalf of Novo Nordisk solely for the purpose of processing your registration. Your details will not be shared with any parties other than OmniaMed Communications and Novo Nordisk.